Invest in a revolution for #GlobalSurgery

Change for the 5 billion

5 billion people around the world lack access to safe, affordable surgical and anesthesia care1. We are trying to change that by searching for the next generation of inhaled anesthetics.

A major reason so many people lack access to surgery is that current anesthesia drugs require expensive personnel and massive infrastructure to administer. With myriad side effects such as cardiovascular depression, hypotension, respiratory depression, post-operative nausea and vomiting, and more, today's anesthetics are far from ideal.

New anesthetics without the side effects of today's drugs could expand access to surgery by making it faster and less expensive to train new anesthetists and might even enable them to take care of more patients. Expanesthetics is using screening technology based on groundbreaking science to search quickly and efficiently for new inhaled anesthetics that lack the unwanted side effects of today's drugs. If we are successful, we might not only transform the multibillion-dollar global market for anesthetics, we may even bring surgical and anesthesia care within reach for billions around the world.

Over 60 anesthetists have invested in our vision and team2. Will you join them and help us try to bring about a revolution in global surgery?

Discover Expanesthetics

To learn more about our mission, our science, and the investment opportunity, fill out the nearby form to register for the confidential section of our website. You will then get an activation link via email. When you return, you will have the chance to sign a non-disclosure agreement that will give you access to confidential information you can use to help you make your investment decision3.

See this video from the Lancet Commission on Global Surgery to learn more about the importance of surgical care as a public health priority around the world.



________________________

1 Meara JG et al, The Lancet Commission on Global Surgery, "Global Surgery 2030: Evidence and Solutions for Achieving Health, Welfare and Economic Development." Lancet, 2015 Aug 8;386(9993):569-624.

2 As of April 17, 2019.

3 This is not an offer to sell or a solicitation of any offer to buy any securities. Offers are made only by prospectus or other offering materials. Only prospective investors who have been invited to review such materials and meet the suitability standards required by law are eligible to invest. This document includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of Expanesthetics' management and are subject to significant risks and uncertainties. There can be no guarantees. These statements are made as of the date of this communication and Expanesthetics assumes no obligation to provide updates.